Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Liposomal Formulations for Nose-to-Brain Delivery: Recent Advances and Future Perspectives
Soon-Seok Hong, Kyung Taek Oh, Han‐Gon Choi, et al.
Pharmaceutics (2019) Vol. 11, Iss. 10, pp. 540-540
Open Access | Times Cited: 134

Showing 1-25 of 134 citing articles:

RETRACTED: Liposomes: Structure, Biomedical Applications, and Stability Parameters With Emphasis on Cholesterol
Pooria Nakhaei, Ria Margiana, Dmitry Olegovich Bokov, et al.
Frontiers in Bioengineering and Biotechnology (2021) Vol. 9
Open Access | Times Cited: 388
The blood–tumour barrier in cancer biology and therapy
Patricia S. Steeg
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 11, pp. 696-714
Closed Access | Times Cited: 191
Progress in nasal drug delivery systems
Flavia Laffleur, Bettina Bauer
International Journal of Pharmaceutics (2021) Vol. 607, pp. 120994-120994
Closed Access | Times Cited: 119
Pharmacokinetics and Pharmacodynamics of Intranasal Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Nose-to-Brain Delivery
Thi‐Thao‐Linh Nguyen, Han‐Joo Maeng
Pharmaceutics (2022) Vol. 14, Iss. 3, pp. 572-572
Open Access | Times Cited: 74
Recent Advances in Intranasal Liposomes for Drug, Gene, and Vaccine Delivery
Van‐An Duong, Thi‐Thao‐Linh Nguyen, Han‐Joo Maeng
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 207-207
Open Access | Times Cited: 57
Intranasal drug delivery: The interaction between nanoparticles and the nose-to-brain pathway
Yaoxing Chen, Chenyun Zhang, Yukun Huang, et al.
Advanced Drug Delivery Reviews (2024) Vol. 207, pp. 115196-115196
Closed Access | Times Cited: 35
Unravelling the in vivo dynamics of liposomes: Insights into biodistribution and cellular membrane interactions
Sharanya Paramshetti, Mohit Angolkar, Sirajunisa Talath, et al.
Life Sciences (2024) Vol. 346, pp. 122616-122616
Closed Access | Times Cited: 20
Nasal Delivery to the Brain: Harnessing Nanoparticles for Effective Drug Transport
Shivani Gandhi, Divyesh H. Shastri, Jigar Shah, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 481-481
Open Access | Times Cited: 19
Cell-penetrating peptides for transmucosal delivery of proteins
Jiamin Wu, Sophie Roesger, Natalie Jones, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 864-878
Closed Access | Times Cited: 17
Nanoparticle-Based Combinational Strategies for Overcoming the Blood-Brain Barrier and Blood-Tumor Barrier
Su Hyun Lim, Gi Taek Yee, Dongwoo Khang
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 2529-2552
Open Access | Times Cited: 16
Improving Drug Delivery for Alzheimer’s Disease Through Nose-to-Brain Delivery Using Nanoemulsions, Nanostructured Lipid Carriers (NLC) and in situ Hydrogels
Sara Cunha, Ben Forbes, José Manuel Sousa Lobo, et al.
International Journal of Nanomedicine (2021) Vol. Volume 16, pp. 4373-4390
Open Access | Times Cited: 92
Recent progress in nanocarriers for direct nose to brain drug delivery
Nasr A. Emad, Bakr Ahmed, Abdulsalam Alhalmi, et al.
Journal of Drug Delivery Science and Technology (2021) Vol. 64, pp. 102642-102642
Closed Access | Times Cited: 82
Polymeric nanocarriers for nose-to-brain drug delivery in neurodegenerative diseases and neurodevelopmental disorders
Rania Awad, Avi Avital, Alejandro Sosnik
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 5, pp. 1866-1886
Open Access | Times Cited: 64
Exploring the impact of physicochemical properties of liposomal formulations on their in vivo fate
Behjat Sheikholeslami, Nga Wing Lam, Kamal Dua, et al.
Life Sciences (2022) Vol. 300, pp. 120574-120574
Closed Access | Times Cited: 57
Using the Intranasal Route to Administer Drugs to Treat Neurological and Psychiatric Illnesses: Rationale, Successes, and Future Needs
Andrew Lofts, Fahed Abu-Hijleh, Nicolette Rigg, et al.
CNS Drugs (2022) Vol. 36, Iss. 7, pp. 739-770
Open Access | Times Cited: 49
Lipid-Based Nanocarriers for Neurological Disorders: A Review of the State-of-the-Art and Therapeutic Success to Date
Bwalya A. Witika, Madan S. Poka, Patrick H. Demana, et al.
Pharmaceutics (2022) Vol. 14, Iss. 4, pp. 836-836
Open Access | Times Cited: 44
Different Methods and Formulations of Drugs and Vaccines for Nasal Administration
Junhu Tai, Mun Soo Han, Dabin Lee, et al.
Pharmaceutics (2022) Vol. 14, Iss. 5, pp. 1073-1073
Open Access | Times Cited: 44
Improving outcomes in intracerebral hemorrhage through microglia/macrophage-targeted IL-10 delivery with phosphatidylserine liposomes
Ranran Han, Xi Lan, Zheng Han, et al.
Biomaterials (2023) Vol. 301, pp. 122277-122277
Closed Access | Times Cited: 30
Niosomes for nose-to-brain delivery: A non-invasive versatile carrier system for drug delivery in neurodegenerative diseases
Alaa Raad Al Jayoush, Hatem A. F. M. Hassan, Hawraa Asiri, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 89, pp. 105007-105007
Closed Access | Times Cited: 28
Intranasal Drug Administration in Alzheimer-Type Dementia: Towards Clinical Applications
Raquel Taléns‐Visconti, Jesús Vicente de Julián-Ortiz, Ofelia Vila-Busó, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1399-1399
Open Access | Times Cited: 27
A comprehensive insight of innovations and recent advancements in nanocarriers for nose-to-brain drug targeting
Naeem Mubarak, Muhammad Ahsan Waqar, Asad Majeed Khan, et al.
Designed Monomers & Polymers (2025) Vol. 28, Iss. 1, pp. 7-29
Open Access | Times Cited: 1
RVG29-modified microRNA-loaded nanoparticles improve ischemic brain injury by nasal delivery
Rubin Hao, Bixi Sun, Lihua Yang, et al.
Drug Delivery (2020) Vol. 27, Iss. 1, pp. 772-781
Open Access | Times Cited: 54
Design, development and in-vitro/in-vivo evaluation of intranasally delivered Rivastigmine and N-Acetyl Cysteine loaded bifunctional niosomes for applications in combinative treatment of Alzheimer’s disease
Pratik Kulkarni, Deepak Rawtani, Tejas Barot
European Journal of Pharmaceutics and Biopharmaceutics (2021) Vol. 163, pp. 1-15
Closed Access | Times Cited: 54
Pharmacokinetic and pharmacodynamic evaluation of nasal liposome and nanoparticle based rivastigmine formulations in acute and chronic models of Alzheimer’s disease
Sampath Kumar L. Rompicherla, Karthik Arumugam, Sree Lalitha Bojja, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2021) Vol. 394, Iss. 8, pp. 1737-1755
Open Access | Times Cited: 53
Nose-to-brain delivery of antipsychotics using nanotechnology: a review
Madeleine S. A. Tan, Harendra S. Parekh, Preeti Pandey, et al.
Expert Opinion on Drug Delivery (2020) Vol. 17, Iss. 6, pp. 839-853
Closed Access | Times Cited: 52
Page 1 - Next Page

Scroll to top